Therapy of Obesity and Diabetes Mellitus Type 2

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
ObesityDiabetes Type 2Weight Loss
Interventions
OTHER

Structured weight-loss program

"During the fasting phase, daily consumption consists of five sachets fully replacing normal food and corresponded to an energy content of 800 kcal. This fasting phase is followed by a four-week refeeding phase, during which regular food will be reintroduced and formula diet is gradually replaced until a daily total intake of 1200 kcal is reached. During the last five weeks of the program, energy intake is gradually increased to an individual level between 1200 kcal and 1500 kcal that allowed subjects to keep their weight stable.~Once a week participants visit the study center to monitor health status and taking part in supervised exercises and a nutritional and behavioral counseling."

Trial Locations (1)

17475

University Medicine Greifswald, Greifswald

All Listed Sponsors
lead

University Medicine Greifswald

OTHER

NCT02970838 - Therapy of Obesity and Diabetes Mellitus Type 2 | Biotech Hunter | Biotech Hunter